SEC 13F Intelligence

Rock Springs Capital Management LP / ACAD

Rock Springs Capital Management LP’s Acadia Pharmaceuticals Inc Position

Does Rock Springs Capital Management LP own Acadia Pharmaceuticals Inc (ACAD)? Not currently — the last reported position was 1.00M shares worth $24M in Q2 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$24M
Q2 2021
Shares
1.00M
% of Portfolio
+0.48%
Quarters Held
8
position exited

Position History ACAD

Reported value by quarter
Q3 ’19: $7MQ3 ’19Q4 ’19: $29MQ4 ’19Q1 ’20: $43MQ1 ’20Q2 ’20: $51MQ2 ’20Q3 ’20: $65MQ3 ’20Q4 ’20: $86MQ4 ’20Q1 ’21: $28MQ1 ’21Q2 ’21: $24MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20211.00M$24M+0.48%
Q1 20211.08M$28M+0.61%
Q4 20201.61M$86M+1.83%
Q3 20201.57M$65M+1.65%
Q2 20201.05M$51M+1.40%
Q1 20201.02M$43M+1.79%
Q4 2019670.0K$29M+0.91%
Q3 2019187.0K$7M+0.27%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rock Springs Capital Management LP’s full portfolio or all institutional holders of ACAD.